Prestige Consumer Healthcare Inc. (NYSE:PBH) Shares Purchased by Thrivent Financial for Lutherans

Thrivent Financial for Lutherans increased its holdings in shares of Prestige Consumer Healthcare Inc. (NYSE:PBH - Free Report) by 37.3% during the 2nd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 59,152 shares of the company's stock after buying an additional 16,081 shares during the period. Thrivent Financial for Lutherans owned about 0.12% of Prestige Consumer Healthcare worth $4,073,000 at the end of the most recent quarter.

A number of other hedge funds also recently added to or reduced their stakes in the business. Covestor Ltd lifted its holdings in Prestige Consumer Healthcare by 21.6% during the 1st quarter. Covestor Ltd now owns 834 shares of the company's stock worth $61,000 after buying an additional 148 shares during the last quarter. Miller Howard Investments Inc. NY boosted its holdings in Prestige Consumer Healthcare by 2.2% in the second quarter. Miller Howard Investments Inc. NY now owns 7,762 shares of the company's stock valued at $534,000 after purchasing an additional 165 shares in the last quarter. EverSource Wealth Advisors LLC raised its holdings in Prestige Consumer Healthcare by 80.6% during the first quarter. EverSource Wealth Advisors LLC now owns 466 shares of the company's stock worth $33,000 after purchasing an additional 208 shares in the last quarter. Parallel Advisors LLC lifted its position in shares of Prestige Consumer Healthcare by 42.5% during the 4th quarter. Parallel Advisors LLC now owns 714 shares of the company's stock worth $44,000 after buying an additional 213 shares during the last quarter. Finally, QRG Capital Management Inc. raised its stake in Prestige Consumer Healthcare by 4.7% during the 2nd quarter. QRG Capital Management Inc. now owns 5,397 shares of the company's stock worth $372,000 after acquiring an additional 242 shares in the last quarter. 99.95% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

Several equities research analysts have recently weighed in on the company. Jefferies Financial Group reissued a "hold" rating and issued a $76.00 price objective (up from $70.00) on shares of Prestige Consumer Healthcare in a report on Tuesday, September 24th. DA Davidson upped their price objective on shares of Prestige Consumer Healthcare from $93.00 to $95.00 and gave the stock a "buy" rating in a research report on Wednesday, August 28th. Two equities research analysts have rated the stock with a hold rating and four have assigned a buy rating to the stock. Based on data from MarketBeat, Prestige Consumer Healthcare currently has a consensus rating of "Moderate Buy" and an average target price of $94.20.

Prestige Consumer Healthcare Trading Down 0.0 %

NYSE:PBH traded down $0.03 during mid-day trading on Friday, reaching $71.32. The company's stock had a trading volume of 189,348 shares, compared to its average volume of 225,721. Prestige Consumer Healthcare Inc. has a twelve month low of $56.34 and a twelve month high of $75.80. The company's fifty day simple moving average is $71.21 and its two-hundred day simple moving average is $69.60. The company has a debt-to-equity ratio of 0.65, a current ratio of 3.23 and a quick ratio of 1.90. The stock has a market cap of $3.53 billion, a P/E ratio of 17.10, a P/E/G ratio of 2.01 and a beta of 0.48.

Prestige Consumer Healthcare (NYSE:PBH - Get Free Report) last posted its quarterly earnings results on Thursday, August 8th. The company reported $0.90 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.86 by $0.04. Prestige Consumer Healthcare had a return on equity of 12.55% and a net margin of 18.43%. The firm had revenue of $267.10 million during the quarter, compared to the consensus estimate of $260.54 million. During the same quarter in the previous year, the business earned $1.06 earnings per share. The firm's quarterly revenue was down 4.4% compared to the same quarter last year. On average, equities analysts predict that Prestige Consumer Healthcare Inc. will post 4.43 EPS for the current year.

Prestige Consumer Healthcare Company Profile

Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare.